中国医学创新Issue(4)：145-148,4.DOI:10.3969/j.issn.1674-4985.2016.04.042
肿瘤标志物在肺癌诊疗中的研究进展
The Current Status of Tumor Markers in Lung Cancer
摘要
Abstract
The determination of tumor markers is of great value for early diagnosis. It is not only helpful in clinical staging and classification of pathological types in patients with lung cancer, but also useful in evaluation of prognosis and response to treatment.This article reviews the current status of tumor markers in lung cancer,such as CEA,ProGRP,CYFRA21-1,NSE,SCC,and so on.关键词
肺癌/肿瘤标志物/诊断Key words
Lung cancer/Tumor markers/Diagnosis引用本文复制引用
郑名华,孙国栋,张郧樊,杨建新..肿瘤标志物在肺癌诊疗中的研究进展[J].中国医学创新,2016,(4):145-148,4.
